ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,860Medicare Part D Prescriptions Filled, Including Refills

Rank: 37 out of 623

$299K Total Retail Price of All Prescriptions

Rank: 117 out of 623

333 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
75% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maryland
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

9% of this provider’s 333 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

1% of this provider’s 6,240 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$38 was the average price of a prescription from this provider, compared to $66 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maryland
SIMVASTATIN 492 437 1 2
LISINOPRIL 471 375 2 1
AMLODIPINE BESYLATE 366 303 3 3
HYDROCHLOROTHIAZIDE 335 262 4 8
METOPROLOL TARTRATE 290 250 5 9
FUROSEMIDE 243 218 6 5
METFORMIN HCL 232 191 7 6
ATENOLOL 217 182 8 12
OMEPRAZOLE 181 130 9 7
GLIPIZIDE 172 139 10 33
LEVOTHYROXINE SODIUM 155 129 11 4
POTASSIUM CHLORIDE 143 135 12 24
TRAMADOL HCL 133 91 13 15
FELODIPINE ER 113 102 14 154
RANITIDINE HCL 110 100 15 23
ATORVASTATIN CALCIUM 109 90 16 10
ALENDRONATE SODIUM 107 107 17 37
DONEPEZIL HCL 103 103 18 27
LOSARTAN POTASSIUM 99 96 19 16
TRIAMTERENE-HCTZ 96 81 20 74
ZETIA 94 68 21 99
NIFEDIPINE ER 90 77 22 90
FLUTICASONE PROPIONATE 81 67 23 29
METOPROLOL SUCCINATE 80 69 24 13
INSULIN SYRINGE 73 70 25 80
ACETAMINOPHEN-CODEINE 72 65 S3 26 81
VERAPAMIL ER 68 56 27 104
PRAVASTATIN SODIUM 66 52 28 11
GABAPENTIN 65 29 29 18
WARFARIN SODIUM 63 50 30 14
SERTRALINE HCL 59 34 31 20
LANTUS 58 50 32 41
ISOSORBIDE MONONITRATE ER 57 41 33 64
TRAZODONE HCL 55 36 34 36
GLYBURIDE 55 40 R 34 103
PLAVIX 55 46 34 46
VENTOLIN HFA 53 39 37 92
NAPROXEN 52 40 38 89
GEMFIBROZIL 51 51 39 110
ADVAIR DISKUS 50 49 40 39
CYCLOBENZAPRINE HCL 50 27 R 40 65
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 20, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.